IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences

NEXT STORY
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
PREV STORY
Ronald McDonald House Charities Announces Winners of the 2019 Remarkable Impact Grants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DIAGNOS Adds a Second Screening Site at the CHUM in the Ophthalmology Department

author_avatar
NASDAQ Market News

ABLYNX ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP

REGULATED INFORMATION - INSIDE INFORMATION Caplacizumab meets primary endpoint and key secondary endpoints Statistically ...

author_avatar
NASDAQ Market News

TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601

PRESS RELEASE TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ...

PM360 Staff
PM360 Staff